| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |